HALO - Halozyme Therapeutics Inc.'s (HALO) CEO Helen Torley On Q4 2021 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO) Q4 2021 Earnings Conference Call February 22, 2022 4:30 P.M. ET Company Participants Al Kildani - Vice President of Investor Relations and Corporate Communications Helen Torley - President and Chief Executive Officer Nicole LaBrosse - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Michael DiFiore - Evercore ISI Corinne Jenkins - Goldman Sachs Jessica Fye - JP Morgan Jason Butler - JMP Securities Anita Dushyanth - Berenberg Capital Markets Joe Catanzaro - Piper Sandler Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:04 Good afternoon everyone. My name is Liza and I will be your conference operator today. At this time,
For further details see:
Halozyme Therapeutics, Inc.'s (HALO) CEO Helen Torley On Q4 2021 Results - Earnings Call Transcript